Hot Pursuit     07-Jun-24
Biocon Ltd spurts 1.22%, gains for third straight session
Biocon Ltd is quoting at Rs 336.8, up 1.22% on the day as on 12:49 IST on the NSE. The stock is up 39.43% in last one year as compared to a 24.64% gain in NIFTY and a 51.19% gain in the Nifty Pharma index.

Biocon Ltd is up for a third straight session in a row. The stock is quoting at Rs 336.8, up 1.22% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 1.78% on the day, quoting at 23226.9. The Sensex is at 76478.93, up 1.87%. Biocon Ltd has added around 9.71% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has added around 3.55% in last one month and is currently quoting at 19232.1, up 1.5% on the day. The volume in the stock stood at 107.76 lakh shares today, compared to the daily average of 101.91 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 337.3, up 0.9% on the day. Biocon Ltd is up 39.43% in last one year as compared to a 24.64% gain in NIFTY and a 51.19% gain in the Nifty Pharma index.

The PE of the stock is 369.61 based on TTM earnings ending March 24.

Previous News
  Biocon's biologics arm gets Health Canada approval for aflibercept biosimilar 'Yesafili'
 ( Hot Pursuit - 27-Jun-25   12:18 )
  Biocon raises Rs 4,500 crore via QIP
 ( Hot Pursuit - 21-Jun-25   09:13 )
  Restaurant Brands Asia Ltd leads gainers in 'A' group
 ( Hot Pursuit - 19-Jun-25   12:00 )
  Biocon get facilities rated
 ( Corporate News - 18-Jun-25   09:41 )
  Indices drift lower in early trade; breadth positive
 ( Market Commentary - Mid-Session 17-Jun-25   09:37 )
  Biocon Ltd soars 3.52%, Gains for third straight session
 ( Hot Pursuit - 11-Jun-25   13:05 )
  Biocon gets CDSCO approval for Liraglutide drug substance
 ( Hot Pursuit - 03-Jun-25   08:23 )
  Biocon Biologics announces extension of insulin supply agreement with Govt. of Malaysia
 ( Corporate News - 22-May-25   09:19 )
  Biocon Ltd spurts 1.3%, up for five straight sessions
 ( Hot Pursuit - 19-May-25   13:00 )
  Biocon's subsidiary get US FDA nod for anticoagulant medication Rivaroxaban
 ( Hot Pursuit - 16-May-25   09:38 )
  Biocon
 ( Results - Analysis 09-May-25   10:36 )
Other Stories
  ZEN Technologies ends higher after receiving patent for long-pass optical filter
  30-Jun-25   18:44
  Torrent Pharma gains after inking pact to acquire majority stake in JB Chemicals & Pharma
  30-Jun-25   16:02
  Suditi Industries jumps 17% in seven days
  30-Jun-25   15:23
  J B Chemicals & Pharmaceuticals Ltd leads losers in 'A' group
  30-Jun-25   15:00
  Aimtron Electronics gains on inking Rs 98-crore ODM contract with US Firm
  30-Jun-25   14:52
  Sigachi Industries Ltd leads losers in 'B' group
  30-Jun-25   14:45
  Sigachi Industries drops after deadly explosion at Telangana facility
  30-Jun-25   14:32
  Volumes soar at Alembic Pharmaceuticals Ltd counter
  30-Jun-25   14:30
  HEC Infra secures Rs 3-cr work order from Ahmedabad Municipal Corporation
  30-Jun-25   14:26
  Jindal Steel commissions first galvanizing line at Angul Complex
  30-Jun-25   13:40
Back Top